Full-Time

Network Engineer

Confirmed live in the last 24 hours

Medpace, Inc.

Medpace, Inc.

1,001-5,000 employees

No salary listed

Junior, Mid

Cincinnati, OH, USA

The position is office-based, indicating that the candidate will be required to work on-site.

Category
Network Administration
IT & Security
Required Skills
Computer Networking
Requirements
  • Bachelor's degree in a related field
  • Cisco CCNA or CCNP is desired
  • Desire to learn and grow, with a solid foundation of experience
  • Problem-solving and analytical skills
  • Strong documentation skills
  • Time management skills
  • Aptitude to manage many different devices, applications, and priorities effectively
  • Ability to communicate effectively with peers, end users, and management.
Responsibilities
  • Establish and Maintain network performance
  • Build network configurations and connections
  • Troubleshoot network problems
  • Defines, documents, and enforces system standards
  • Maximizes performance by troubleshooting network problems and outages and scheduling upgrades
  • Updates network equipment
  • Collaborates with network architects on network optimization
  • Maintains and coordinates installation of network links
Desired Qualifications
  • Experience with Cisco switching, routing and firewalls
  • Experience with Cisco Call Manager, Call Manager Express, Contact Center, and Unity
  • Experience with Cisco Meraki
  • Experience with Cisco ISE
  • Experience with Cisco DNA
  • Experience with Check Point firewalls
  • Experience with SDWAN from Silver Peak
  • Experience with Solarwinds Monitoring Software

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Irving, Texas

Founded

1992

Simplify Jobs

Simplify's Take

What believers are saying

  • Significant revenue growth in Q4 2023 indicates strong market demand and effective strategies.
  • Recent investments by financial institutions reflect confidence in Medpace's growth potential.
  • Expansion of medical leadership team suggests increased focus on clinical research and development.

What critics are saying

  • Increased competition from Lantheus and others may pressure Medpace's market share.
  • New Cincinnati office construction could lead to higher operational costs and project delays.
  • Decreased net income margin in 2023 indicates challenges in maintaining profitability.

What makes Medpace, Inc. unique

  • Medpace's expansion in infectious diseases and vaccines shows strategic focus on high-demand sectors.
  • New leadership in respiratory and women's health enhances Medpace's expertise and service offerings.
  • Commitment to infrastructure growth with new Cincinnati office supports future operational efficiency.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Unlimited Paid Time Off

Competitive Compensation and Benefits Package

Employee Health and Wellness Initiatives

Hybrid Work Options

Structured Career Paths with Opportunities for Professional Growth

Company News

Financial Modeling Prep
Feb 28th, 2025
Lantheus Holdings, Inc. (NASDAQ:LNTH) Demonstrates Strong Capital Efficiency

Lantheus competes with other companies in the medical and pharmaceutical industries, such as ShockWave Medical, Medpace Holdings, LivaNova, Apellis Pharmaceuticals, and Natera.

Stock Titan
Aug 15th, 2024
Skanska builds new office building in Cincinnati, Ohio, USA, for USD 164M, about SEK 1.7 billion

STOCKHOLM, Aug. 15, 2024 /PRNewswire/ - Skanska has signed a contract with Medpace, a clinical research company, for the construction of a new office building in Cincinnati, Ohio, USA.

MarketBeat
Apr 8th, 2024
First National Bank of Hutchinson Invests $786,000 in Medpace Holdings, Inc. (NASDAQ:MEDP)

First National Bank of Hutchinson invests $786,000 in Medpace Holdings, Inc. (NASDAQ:MEDP).

PharmiWeb
Feb 13th, 2024
Medpace Holdings, Inc. Reports Fourth Quarter And Full Year 2023 Results

Revenue of $498.4 million in the fourth quarter of 2023 increased 26.5% from revenue of $394.1 million for the comparable prior-year period, representing a backlog conversion rate of 18.5%.Net new business awards were $614.7 million in the fourth quarter of 2023, representing an increase of 26.7% from net new business awards of $485.1 million for the comparable prior-year period, which resulted in a net book-to-bill ratio of 1.23x.Fourth quarter of 2023 GAAP net income was $78.3 million, or $2.46 per diluted share, versus GAAP net income of $68.7 million, or $2.12 per diluted share, for the comparable prior-year period. Net income margin was 15.7% and 17.4% for the fourth quarter of 2023 and 2022, respectively.EBITDA was $95.8 million for the fourth quarter of 2023, an increase of 19.2% from EBITDA of $80.4 million for the comparable prior-year period, resulting in an EBITDA margin of 19.2%. CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the fourth quarter and full year ended December 31, 2023. Fourth Quarter 2023 Financial Results

MarketBeat
Feb 2nd, 2024
Hussman Strategic Advisors Inc. Invests $1.02 Million in Medpace Holdings, Inc. (NASDAQ:MEDP)

Hussman Strategic Advisors Inc. invests $1.02 million in Medpace Holdings, Inc. (NASDAQ:MEDP).